98%
921
2 minutes
20
Background: The rise in hot nights over recent decades and projections of further increases due to climate change underscores the critical need to understand their impact. This knowledge is essential for shaping public health strategies and guiding adaptation efforts. Despite their significance, research on the implications of hot nights remains limited.
Objective: This study estimated the association between hot-night excess (the sum of excess heat during the nighttime above a threshold) and duration (the percent of nighttime with a positive excess) based on hourly ambient temperatures and daily mortality in the warm season over multiple locations worldwide.
Methods: We fitted time series regression models to mortality in 178 locations across 44 countries using a distributed lag non-linear model over lags of 0-3 days, controlling for daily maximum temperature and daily mean absolute humidity. Next, we used a multivariate meta-regression model to pool results and estimated attributable burdens.
Results: We found a positive, increasing mortality risk with hot-night excess and duration. Assuming 0 as a reference, the pooled relative risks of death associated with extreme excess and duration, defined as the 90th percentile in each index, were both similar at 1.026 (95 % CI, 1.017; 1.036) and 1.026 (95 % CI, 1.013; 1.040). The overall estimated attributable fractions were also observed to be closely similar at 0.60 % (95 % CI, 0.09; 1.10 %) and 0.62 % (95 % CI, 0.00; 1.23 %), respectively.
Discussion: This study provides new evidence that hot nights have a specific contribution to heat-related mortality risk. Modeling thermal characteristics' sub-hourly impact on mortality during the night could improve decision-making for long-term adaptions and preventive public health strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envint.2025.109719 | DOI Listing |
Ann Med Surg (Lond)
September 2025
Department of Medicine, Georgia State University, Atlanta, USA.
Menopausal vasomotor symptoms (VMS), such as hot flashes and night sweats, significantly impact the quality of life for many women. While hormone therapy remains a standard treatment, it is not suitable for all patients due to contraindications, safety concerns, or personal preferences. Fezolinetant (Veozah), a non-hormonal neurokinin-3 receptor (NK3R) antagonist, has emerged as a novel alternative for managing moderate to severe menopausal VMS.
View Article and Find Full Text PDFAm J Physiol Heart Circ Physiol
September 2025
Division of Physical Therapy and Rehabilitation Science, Department of Family Medicine and Community Health, Medical School, University of Minnesota.
Objectives: While evidence suggests an association between vasomotor symptoms (VMS; hot flushes and night sweats) and elevated blood pressure (BP), it remains unknown whether females who experience VMS have elevated muscle sympathetic nerve activity (MSNA), a major modulator of BP. We hypothesized that postmenopausal females with VMS would have elevated BP and MSNA at rest and during stress compared to age-matched females without VMS.
Methods: Participants were grouped based on whether they currently or previously experienced VMS (n=43) or never experienced VMS (non-VMS; n=26).
Eur J Obstet Gynecol Reprod Biol
August 2025
Fakher Mechatronic Research Center, Kerman University of Medical Sciences, Kerman, Iran; Research Management Centre, INTI International University, Putra Nilai, Malaysia. Electronic address:
Background: Hot flashes and night sweats (HFNS), the primary symptoms of the menopausal transition, can greatly affect women's quality of life. There is substantial evidence that cognitive-behavioral interventions positively influence the management of HFNS in women.
Objective: The aim of this study is to evaluate the effectiveness of a mobile-app-based cognitive-behavioral therapy (Meno-iCBT) on the problem rating of hot flashes and night sweats (HFNS).
Environ Int
August 2025
Spanish Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiology and Public Health-CIBERESP), Madrid, Spain; Department of Statistics and Computational Research. Universitat de València, València, Spain.
Background: The rise in hot nights over recent decades and projections of further increases due to climate change underscores the critical need to understand their impact. This knowledge is essential for shaping public health strategies and guiding adaptation efforts. Despite their significance, research on the implications of hot nights remains limited.
View Article and Find Full Text PDFBJOG
August 2025
Section of Endocrinology and Investigative Medicine, Imperial College London, Hammersmith Hospital, London, UK.
The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
View Article and Find Full Text PDF